This Week in Psychedelics - 10.8.21

Cannabis

• Philadelphia Will Vote On Marijuana Referendum Calling For Statewide Legalization Next Month (Marijuana Moment)

• Top Mexican Senator Lays Out Next Steps For National Marijuana Legalization (Marijuana Moment)

• Nevada: New Marijuana Laws Took Effect This Month (NORML)

• Portugal Delays Recreational Cannabis Bills as Luxembourg Also Signals Delay (High Times)

• New York: Regulators Approve Patients’ Access to Medical Cannabis Flower (NORML)

• NBA Won’t Randomly Drug Test Players For Marijuana For Another Season, League Announces (Marijuana Moment)

• Lung Injuries Tied To Contaminated Vapes Were Less Common In States With Legal Marijuana And Homegrow, Study Finds (Marijuana Moment)

• California Legalizes Smokable Hemp and Food Sales in Historic Bill (High Times)

• Preconception cannabis use linked to an increased risk of postpartum depression (PsyPost)

• More Than A Dozen Ohio Cities Will Vote On Marijuana Decriminalization Ballot Measures Next Month (Marijuana Moment)

• CBGA More Effective For Seizures Than CBD, Study of Mice Finds (High Times)

• Study: Cannabis Use Disorder Diagnosis Associated with Greater Risk of COVID Breakthrough Infections — NORML Responds (NORML)

• Bipartisan Pennsylvania Senators Unveil Marijuana Legalization Bill Amid Whirlwind Of Reform Efforts In The State (Marijuana Moment)

• Oklahoma Activists File Marijuana Legalization And Medical Cannabis Reform Initiatives For 2022 Ballot (Marijuana Moment)

LSD

• Inside the World’s Largest Collection of Acid Tabs (DoubleBlind)

• Acid Communism (Daniel Pinchbeck)

Magic Mushrooms

• GOP Pennsylvania Lawmaker Files Psilocybin Research Bill For Veterans And First Responders (Marijuana Moment)

• Denver may ease magic mushrooms laws further two years after decriminalization (The Denver Post)

• Is Denver’s Psilocybin Decriminalization Having an Impact? (Filter)

• Psychedelic drug changes the emotional state of people listening to music (News-Medical.net)

• "Homebrew" Psilocybin Created By Scientists Using "Widely Available" Materials (IFLScience)

• Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr. Matthew Johnson (Mydecine)

• Psygen Announces use of Psilocybin in Human Trial and Provides Update on IP Portfolio (Psilocybin Alpha)

• Psyched Wellness Announces Commencement of Next Pre-Clinical Study on AME-1 (Psilocybin Alpha)

MDMA

• Why You Vom When You’re Coming Up On MDMA (VICE)

• MDMA-assisted psychotherapy associated with sleep improvements among PTSD patients (PsyPost)

Peyote

• Santa Cruz Removes Peyote And Other Mescaline-Containing Cacti From Psychedelics Decriminalization Law (Marijuana Moment)

Novel Psychoactive Substances

• Psychedelic Capital: Novel Psychedelic Molecules (Truffle Report)

Ketamine

• Recreational ketamine use has increased in recent years, but remains rare (Medical Xpress)

• PharmaTher Initiates Phase 2 Clinical Trial of Ketamine for the Treatment of Parkinson’s Disease (Psilocybin Alpha)

Miscellaneous

• Seattle Becomes Largest U.S. City To Decriminalize Psychedelics (Marijuana Moment)

• Arcata, California Decriminalizes Psychedelics (Truffle Report)

• The Psychedelics Industry Could Offer a Whole New Approach to Work (Rolling Stone)

• Will Smith Recalls Life-Changing Psychedelic Experiences in New Book (High Times)

• PSYCH Publishes Third Edition of The Psychedelics as Medicine Report (PR Newswire)

• Toronto’s Bid to Decriminalize Drugs Hangs in the Balance (Filter)

• The Need for New Psychedelic Compounds (Psychology Today)

• Risks of Serotonin Syndrome when Combining Psychedelics with Antidepressants (Chacruna)

• The 'Psychedelic Renaissance' Is Entirely About Corporate Greed (Caitlin Johnstone)

• Becoming a Yes-Sayer: Psychedelics, Nietzsche, and the Affirmation of Life (Sam Woolfe)

• Will Psychedelic Companies Embrace Indigenous Reciprocity? (Lucid News)

• What Is Hallucinogen-Persisting Perception Disorder (HPPD)? (PsychCentral)

• Anima Mundi: Psychedelics and The Ensouled Earth (Psychedelics Today)

• Ensuring Equity in Psychedelic Science and Businesses (Truffle Report)

• Death and psychedelics: How science is reviving this ancient connection (Leafly)

• DoubleBlind Claims Its Ad Was the ‘First-Ever’ U.S. Psychedelic Destigmatization Campaign — It Wasn’t (Psymposia)

• Psychedelic-Induced Psychological Flexibility Can Reduce Racial Trauma (Truffle Report)

• Tryp Therapeutics Announces Collaboration with Researchers at the University of Wisconsin-Madison (Psilocybin Alpha)

• Psychedelics and Mental Health Therapy in Colorado: DORA and Potential Regulatory Response (JD Supra)

• Psychedelics and Perception Part 2: The First Era of Research (Psychedelic Science Review)

• It’s one big mistake (New Amsterdam Psychedelic Law)

• Madison Margolin Sounds Off on Mainstreaming of Cannabis and Psychedelics Cultures (CelebStoner)

• Numinus Upgrades Psychedelics Lab to Increase Research Service Capabilities (PR Newswire)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.2.20

Cannabis

• FBI: Marijuana Arrests Decline Year-Over-Year, But Still Outpace Arrests for All Violent Crimes (NORML)

• Colorado Governor Grants Thousands Of Marijuana Pardons With New Clemency Powers (Marijuana Moment)

• New Jersey: Lawmakers Approve Telemedicine for Medical Cannabis Authorizations (NORML)

• Hawaii: Governor Legalizes Sales of Edible Products by Licensed Medical Cannabis Dispensaries (NORML)

• Democrats Remove Marijuana Research Bill From House Floor Schedule After Briefly Listing Possible Vote (Marijuana Moment)

• Michigan: Lawmakers Approve Marijuana Expungement Legislation (NORML)

• Where President Donald Trump Stands On Marijuana (Marijuana Moment)

• New Jersey: Voter Support Solidly in Favor of Marijuana Legalization Ahead of Ballot Initiative Vote (NORML)

• Study: Nearly Thirty Percent of Women Report Having Used Cannabis for Menopause Symptoms (NORML)

LSD

• LSD, Music, and the Mysteries of Consciousness (Psychedelic Science Review)

• Crystal Structure of LSD & 5-HT2AR- Part 1: Capturing the First Steps of a Psychedelic Trip (Psychedelic Science Review)

Magic Mushrooms

• Oregon Psilocybin Initiative Gets Boost From New TV Ad But Draws Opposition From Unlikely Source (Marijuana Moment)

• Psygen Labs To Supply NeonMind With Psilocybin For Weight Loss Study (Green Market Report)

• Denver Mushroom Dealer Pleads Guilty in Federal Court (Westword)

• Psilocybin Patents: Predictors and Drivers of Company Value? (Psilocybin Alpha)

MDMA

• ATAI Life Sciences Company, EmpathBio, Dives Into MDMA Derivatives, Calls MAPS’ Approach “MDMA 1.0” (Psymposia)

• LGBTQIA Providers and Participants in MDMA Clinical Trials with Terence Ching (Chacruna)

DMT

• Combatting resistant depression with DMT and digital therapy (Health Europa)

Ayahuasca

• Dating My Ayahuasca Shaman: Sex, Power, and Consent (Chacruna)

• Women’s Historical Influence on “Set and Setting” (Chacruna)

Iboga

• In Defending Hunter, Biden Showed Us His Potential (Rolling Stone)

• Why Ibogaine Is Not the Answer to the Opioid Crisis (Chacruna)

Synthetic Cannabinoids

• Crystal Structure of CB1 and MDMB-Fubinaca Gives Insight Into Synthetic Cannabinoids’ Potency (Psychedelic Science Review)

Ketamine

• Statement on Ketamine Sedation and Law Enforcement from the American College of Medical Toxicology (PR Web)

• Study reveals how subanesthetic ketamine is effective in treating adult amblyopia (News-Medical.net)

• A Dose of Ketamine Can Treat 'Lazy Eye' in Adults (Futurity)

Miscellaneous

• Psychedelic Gold Rush? Psilocybin Startup Compass Pathways Goes Public at More than $1B (DoubleBlind)

• Michigan Prosecutor Won’t Pursue Psychedelics Possession Cases Following Local Decriminalization Vote (Marijuana Moment)

• Decriminalize Nature Promotes New Oakland Initiative While Condemning Fellow Activists (Lucid News)

• Vermont Democratic Party Platform Calls For Decriminalizing Drugs And Legalizing Marijuana Sales (Marijuana Moment)

• Field Trip Psychedelics Inc. Announces Successful GLP Synthesis, Results From Initial Preclinical Testing for FT-104, its First Molecule in Development (PR Newswire)

• Psychedelics as a Catalyst for Existential Joy (Sam Woolfe)

• ‘The Word of God in a Molecule’: Turning to Psychedelics During a Pandemic (Bedford + Bowery)

• Did Early Christians Use Psychedelics? (The Daily Beast)

• Mydecine Innovations Group Announces The Official Mindleap Health Mobile App Launch in IOS and Android Stores Today (Psilocybin Alpha)

• Psychedelic-Assisted Therapy in the Post-Pandemic Era (Psychedelic Science Review)

• Psychedelic Industry 101: How to Get Involved (Reality Sandwich)

• The Systemic Culture Problems of the Psychedelics Industry (Lucid News)

• How I Used Psychedelics To Support My Sobriety (Yes, You Read That Right) (mindbodygreen)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.